Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page adds the disease term 'Multiple myeloma' and a related topics entry for MedlinePlus Genetics. The revision tag is updated from v3.5.2 to v3.5.3.
    Difference
    0.2%
    Check dated 2026-04-30T02:57:47.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Updated the page’s footer/version indicator to **Revision: v3.5.2** and removed some generic “related topics” link text.
    Difference
    0.2%
    Check dated 2026-04-22T18:02:29.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added related topics: Multiple Myeloma and MedlinePlus Genetics to the study page.
    Difference
    0.2%
    Check dated 2026-04-15T16:11:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Related topics and the disease label 'Multiple myeloma' plus the 'MedlinePlus Genetics' link were removed; core study information remains unchanged.
    Difference
    0.2%
    Check dated 2026-04-08T07:42:34.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added the topic Multiple myeloma and the related topic MedlinePlus Genetics. Updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-24T22:57:25.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Removed the disease label 'Multiple myeloma,' the related topics header, and the 'MedlinePlus Genetics' resource.
    Difference
    0.2%
    Check dated 2026-03-17T20:21:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.